| Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer JM Hou, MG Krebs, L Lancashire, R Sloane, A Backen, RK Swain, ... Journal of clinical oncology 30 (5), 525-532, 2012 | 970 | 2012 |
| Partial Granger causality—Eliminating exogenous inputs and latent variables S Guo, AK Seth, KM Kendrick, C Zhou, J Feng Journal of neuroscience methods 172 (1), 79-93, 2008 | 279 | 2008 |
| Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse F Chemi, DG Rothwell, N McGranahan, S Gulati, C Abbosh, SP Pearce, ... Nature medicine 25 (10), 1534-1539, 2019 | 170 | 2019 |
| Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma L Khoja, P Lorigan, C Zhou, M Lancashire, J Booth, J Cummings, ... Journal of Investigative Dermatology 133 (6), 1582-1590, 2013 | 154 | 2013 |
| Cumulative antibiotic use significantly decreases efficacy of checkpoint inhibitors in patients with advanced cancer N Tinsley, C Zhou, G Tan, S Rack, P Lorigan, F Blackhall, M Krebs, ... The oncologist 25 (1), 55-63, 2020 | 146 | 2020 |
| Circulating tumor cells detected in the tumor-draining pulmonary vein are associated with disease recurrence after surgical resection of NSCLC PAJ Crosbie, R Shah, P Krysiak, C Zhou, K Morris, J Tugwood, R Booton, ... Journal of Thoracic Oncology 11 (10), 1793-1797, 2016 | 96 | 2016 |
| Circulating biomarkers in hepatocellular carcinoma KL Morris, JD Tugwood, L Khoja, M Lancashire, R Sloane, D Burt, ... Cancer chemotherapy and pharmacology 74, 323-332, 2014 | 78 | 2014 |
| The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancer A Backen, AG Renehan, AR Clamp, C Berzuini, C Zhou, A Oza, S Bannoo, ... Clinical Cancer Research 20 (17), 4549-4558, 2014 | 74 | 2014 |
| Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery C Zhou, KL Simpson, LJ Lancashire, MJ Walker, MJ Dawson, RD Unwin, ... Journal of proteome research 11 (4), 2103-2113, 2012 | 71 | 2012 |
| Profiling of circulating free DNA using targeted and genome-wide sequencing in patients with SCLC S Mohan, V Foy, M Ayub, HS Leong, P Schofield, S Sahoo, T Descamps, ... Journal of Thoracic Oncology 15 (2), 216-230, 2020 | 59 | 2020 |
| Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer GC Jayson, C Zhou, A Backen, L Horsley, K Marti-Marti, D Shaw, ... Nature communications 9 (1), 4672, 2018 | 50 | 2018 |
| A machine learning approach to explore the spectra intensity pattern of peptides using tandem mass spectrometry data C Zhou, LD Bowler, J Feng BMC bioinformatics 9, 1-17, 2008 | 50 | 2008 |
| Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer S Mohan, M Ayub, DG Rothwell, S Gulati, B Kilerci, A Hollebecque, ... Scientific reports 9 (1), 11610, 2019 | 45 | 2019 |
| A caspase-3 ‘death-switch’in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell … KL Simpson, C Cawthorne, C Zhou, CL Hodgkinson, MJ Walker, ... Cell death & disease 4 (5), e613-e613, 2013 | 40 | 2013 |
| Discovery and validation of predictive biomarkers of survival for non-small cell lung cancer patients undergoing radical radiotherapy: two proteins with predictive value MJ Walker, C Zhou, A Backen, M Pernemalm, AJK Williamson, LJC Priest, ... EBioMedicine 2 (8), 841-850, 2015 | 33 | 2015 |
| Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab C Zhou, A Clamp, A Backen, C Berzuini, A Renehan, RE Banks, R Kaplan, ... British journal of cancer 115 (2), 228-235, 2016 | 32 | 2016 |
| Cumulative antibiotic use and efficacy of immune checkpoint inhibitors in patients with advanced cancer. N Tinsley, C Zhou, S Villa, G Tan, P Lorigan, FH Blackhall, T Elliott, ... Journal of Clinical Oncology 36 (15_suppl), 3010-3010, 2018 | 30 | 2018 |
| Method validation of circulating tumour cell enumeration at low cell counts J Cummings, K Morris, C Zhou, R Sloane, M Lancashire, D Morris, ... BMC cancer 13, 1-8, 2013 | 22 | 2013 |
| A hierarchical statistical modeling approach to analyze proteomic isobaric tag for relative and absolute quantitation data C Zhou, MJ Walker, AJK Williamson, A Pierce, C Berzuini, C Dive, ... Bioinformatics 30 (4), 549-558, 2014 | 19 | 2014 |
| TIAM1-RAC1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change A Payapilly, R Guilbert, T Descamps, G White, P Magee, C Zhou, A Kerr, ... Cell Reports 37 (6), 2021 | 17 | 2021 |
Caroline DiveProfessor of Pharmacology, University of ManchesterVerified email at cruk.manchester.ac.uk
